Toward precision oncology: SERS microfluidic systems for multiplex biomarker analysis in liquid biopsy-Reference-Cited by-同舟云学术

Toward precision oncology: SERS microfluidic systems for multiplex biomarker analysis in liquid biopsy

Published:2022 Issue:3 Volume:3 Page:1459-1471
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Shanmugasundaram Karthik Balaji¹^ORCID,Li Junrong¹^ORCID,Sina Abu Ibn¹^ORCID,Wuethrich Alain¹^ORCID,Trau Matt¹²^ORCID

Affiliation:

1. Center for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), Corner College and Cooper Roads (Bldg 75), The University of Queensland, Brisbane, QLD 4072, Australia

2. School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia

Abstract

Liquid biopsy-based diagnosis in precision oncology exhibits significant advantages over the traditional tissue biopsies by offering dynamic assessment of tumour heterogeneity, minimally invasive procedures for frequent sampling, and cost-effective tests.

Funder

Commonwealth Scientific and Industrial Research Organisation

Australian Research Council

National Health and Medical Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2022/MA/D1MA00848J

Reference51 articles.

1. Preparing for Precision Medicine